Adma Biologics (ADMA) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for...

CL has witnessed consistent growth, with the stock reaching a new 52-week high. Leadership in the oral care market and innovations bolster its...

CL has witnessed consistent growth, with the stock reaching a new 52-week high. Leadership in the oral care market and innovations bolster its...

CLX looks poised for growth through recent recovery, improved distribution channels, and focus on innovation and expansion, amid inflation and cost...

International Flavors (IFF) gains from its strategic actions and focus on growth.

KRYS has gained 21.9% in the past three months on strong uptake of its newly approved drug Vyjuvek and encouraging pipeline progress.

Is it a good or bad thing when a stock surpasses resistance at the 20-day simple moving average?

The average brokerage recommendation (ABR) for Adma Biologics (ADMA) is equivalent to a Buy. The overly optimistic recommendations of Wall Street...

PNC hits a new 52-week high driven by the Fed's indication of a rate cut starting next month.

VBNK hits a 52-week high following its buyout of SBH and the launch of RPP, a digital funding solution that provides lending to individuals and small...